ReleaseWire Connect

In breaking news regarding the DePuy hip recall trial currently underway in Los Angeles, a former Johnson & Johnson (JNJ) DePuy branch president has given testimony regarding the recalled DePuy ASR devices. The DePuy hip recall trial in Los Angeles state court is the first court where DePuy is presenting evidence of defense of negligence in the first 10,000 recalled DePuy ASR hip implant systems. In the current case, Loren Kransky, a former prison guard has claimed the devices were defective, and JNJ failed to warn patients and surgeons of the risk. JNJ has recalled over 93,000 of the ASR hip implants and is facing legal battles in several courts. The current DePuy hip recall trial in Los Angeles represents an important landmark in this recall as it is the first to take place in open court.

Notable bioengineering expert Professor Dennis Bobyn of McGill University has testified regarding the Johnson & Johnson division DePuy ASR hip replacement recall. The information shared by Prof. Bobyn with the State Court of Los Angeles in the first of the major trials involving DePuy was significant. According to Prof. Bobyn, all 93,000 of the metal hip implants suffered from several defects. The defects stemmed from design flaws in the DePuy device which lead to much greater rate of failure than other similar devices. Professor Bobyn testified as an expert witness on behalf of plaintiff Loren Kransky, a former prison guard who filed suit due to his failed DePuy ASR hip replacement.

The first of nearly ten thousand lawsuits regarding the Johnson & Johnson subsidiary DePuy and the defective and recalled DePuy ASR Hip Resurfacing System is currently underway in Los Angeles. Early witnesses and testimony have brought several significant facts to light in this case. Csengeri Law is keeping careful watch over the recalled DePuy ASR hip recall cases nationwide, to offer up to the minute advice and counsel for patients suffering from a recalled DePuy hip implant. In the most current events, testimony has been given by a reputable California surgeon that links high level DePuy employees to potential knowledge regarding the recalled implants.

Csengeri Law is maintaining up to the minute records on the results of the Stryker Orthopaedics Rejuvenate Modular Hip System recall, and developments regarding the recall, in order to assist California patients suffering due to the recall. In July, Stryker announced that it was officially recalling the Rejuvenate Modular Hip System citing “a potential for fretting and corrosion.” Since the July 2012 announcement that Stryker was officially launching the defective Rejuvenate Modular Hip System recall, Csengeri Law has maintained extensive records on filings against Stryker. Csengeri Law has monitored each case carefully in state and federal court, to ensure a complete understanding for California patients suffering due to the Rejuvenate Modular Hip System recall. Csengeri Law has added the information surrounding the Stryker Rejuvenate modular hip system recall to their extensive library of faulty implant related law. Csengeri Law has significant experience in faulty and defective implant law. Ordinarily in cases of fretting and corrosion, particularly when associated with metallosis, it is the result of a faulty or defective metal-on-metal hip implant.

Csengeri Law is aggressively monitoring the first of the nations’ DePuy ASR hip replacement lawsuit, which is scheduled to begin on January 23rd in Los Angeles Superior Court. The lawsuit revolves around the DePuy ASR recall that began in August of 2010. The 2010 recall was nearly a year and a half after the initial lawsuits we filed against DePuy involving defects and health risks associated with the metal-on-metal ASR implants. In 2009, the Food and Drug Administration (FDA) informed DePuy that a similar artificial hip device that was marketed abroad would not be saleable in the United States. Shortly after receiving the FDA information, DePuy began phasing out two all-metal implants that were sold in the US.

Csengeri Law understands full well the pain, difficulty and suffering that a defective metal-on-metal hip implant can cause. The Stryker ABG-II modular neck hip stem and Stryker Rejuvenate hip replacement system are not traditional metal on metal implants, but patients continue to suffer the same health issues as faulty metal on metal implants. This is due to the construction of the Stryker Implants, which utilize some metal components. These components offer several health risks to implant patients. According to Stryker, “these risks include the potential for fretting and/or corrosion at or about the modular-neck junction, which may result in adverse local tissue reaction, as well as possible pain and/or swelling, in or around your hip.”

Lawsuits continue to mount regarding the July 6 recall of the Stryker Orthopaedics ABG-II modular neck hip stem and Stryker Rejuvenate hip replacement system. In the wake of the July 6, 2012 recall, nearly twenty-thousand Stryker hip replacement systems and components have been recalled. The Stryker recall is notable because both the ABG-II modular neck hip stem, and the Rejuvenate hip replacement system, were marketed as an alternative to the increasingly unpopular metal-on-metal joint implant systems. While the Stryker implants are not direct metal-on-metal implants, they contain components that can abrade and cause the same problems that metal-on-metal implants do. Csengeri Law is available to answer questions of patients who have suffered from a defective implant, or need a revision surgery in the wake of the Stryker recall.

Csengeri Law is currently offering free consultations to any patient with questions or concerns about the ongoing recall of the Stryker Rejuvenate hip replacement implant. In July 2012, Stryker issued a voluntary recall on the Rejuvenate hip replacement system. While the Rejuvenate is not a metal-on-metal hip replacement device, it uses metallic components that cause the same health problems and risks that older metal-on-metal implants pose patients. Stryker has cited “While modular-neck hip stems provide surgeons with an option to correct certain aspects of a patient’s anatomy and hip biomechanics, we decided to voluntarily recall these modular-neck hip systems due to the potential for fretting and corrosion at the modular-neck junction which may result in ALTR (adverse local tissue reactions), as well as possible pain and/or swelling at or around the hip.”

Stryker Orthopaedics has recently offered new advice and new options for patients with a defective ABG-II modular neck hip stem implant. In June 2012 Stryker issues the official recall, citing a “potential for fretting and corrosion at the modular-neck junction which may result in ALTR (adverse local tissue reactions), as well as possible pain and/or swelling at or around the hip.” At the time of the recall, Stryker issued advice stating that patients who had experienced no difficulty from the device should continue on as normal.

Csengeri Law is offering up to date information on the legal standing of Stryker hip recall patients. Along with up to date, information Csengeri Law is offering free consultations to anyone who has suffered or required a revision surgery, due to a defective or recalled Stryker hip implant. Through 2011, the FDA gathered extensive post market data that showed that metal-on-metal hip implants, particularly of the ball and cup variety, show the potential for major side effects.